Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Yoshiko, Tsuchihashi"'
Autor:
Yoshiro Yamashita, Ikkoh Yasuda, Takeshi Tanaka, Toru Ikeda, Mayumi Terada, Masahiro Takaki, Yoshiko Tsuchihashi, Norichika Asoh, Yukiko Ohara, Shymaa Enany, Haruka Kobayashi, Sohkichi Matsumoto, Konosuke Morimoto
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/7ed8d03cfa454e94acb3cac361102ff3
Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis
Autor:
Yoshiro Yamashita, Ikkoh Yasuda, Takeshi Tanaka, Toru Ikeda, Mayumi Terada, Masahiro Takaki, Yoshiko Tsuchihashi, Norichika Asoh, Yukiko Ohara, Shymaa Enany, Haruka Kobayashi, Sohkichi Matsumoto, Konosuke Morimoto
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionControlling pulmonary Mycobacterium avium complex (MAC) disease is difficult because there is no way to know the clinical stage accurately. There have been few attempts to use cell-mediated immunity for diagnosing the stage. The objective
Externí odkaz:
https://doaj.org/article/53d1230fdc42406385badddf65e11bf8
Autor:
Irina Chon, Reiko Saito, Akinobu Hibino, Ren Yagami, Clyde Dapat, Takashi Odagiri, Hiroki Kondo, Isamu Sato, Shinji Kimura, Takashi Kawashima, Naoki Kodo, Hironori Masaki, Norichika Asoh, Yoshiko Tsuchihashi, Hassan Zaraket, Yugo Shobugawa
Publikováno v:
Vaccine: X, Vol 1, Iss , Pp - (2019)
Background: We estimated influenza vaccine effectiveness (VE) in 2015–2016 season against medically attended, laboratory-confirmed influenza, when quadrivalent inactivated vaccine (IIV4) was first introduced in Japan, using test-negative case-contr
Externí odkaz:
https://doaj.org/article/15aaf45b4ee04485b9dd391fb7eac96e
Autor:
Nobuo Nagata, Tadashi Saito, Naoki Kodo, Keita Wagatsuma, Norichika Asoh, Isamu Sato, Hirotsune Hamabata, Yasuhiko Ono, Yasushi Shimada, Hidekazu Osada, Kousuke Saito, Reiko Saito, Yoshiko Tsuchihashi, Hironori Masaki, Wint Wint Phyu, Yutaka Shirahige, Irina Chon, Takashi Kawashima
Publikováno v:
Antiviral Research. 188:105036
Baloxavir marboxil has been used for influenza treatment since March 2018 in Japan. After baloxavir treatment, the most frequently detected substitution is Ile38Thr in polymerase acidic protein (PA/I38T), and this substitution reduces baloxavir susce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf98f6a10f348ffc9e044cc777ff44f
https://doi.org/10.1016/j.antiviral.2021.105036
https://doi.org/10.1016/j.antiviral.2021.105036
Autor:
Koichiro Tatsumi, Toshio Ichiwata, Masayuki Hojo, Hideaki Nakayama, Shinya Ohkouchi, Yoshikazu Inoue, Toru Arai, Ryosuke Eda, Etsuro Yamaguchi, Ryushi Tazawa, Yasunori Kasahara, Haruyuki Ishii, Konosuke Morimoto, Toshinori Takada, Masanori Yokoba, Masanori Akira, Yasuyuki Nasuhara, Takahito Nei, Yoshiko Tsuchihashi, Masahito Ebina, Koh Nakata
Publikováno v:
Chest. 145:729-737
Treatment of autoimmune pulmonary alveolar proteinosis (aPAP) by subcutaneous injection or inhaled therapy of granulocyte-macrophage colony-stimulating factor (GM-CSF) has been demonstrated to be safe and efficacious in several reports. However, some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad8f71a9690604d931022d745851d8ea
https://doi.org/10.1378/chest.13-0603
https://doi.org/10.1378/chest.13-0603
Autor:
Norichika Asoh, Yugo Shobugawa, Hiroki Kondo, Ren Yagami, Akinobu Hibino, Shinji Kimura, Yoshiko Tsuchihashi, Hassan Zaraket, Naoki Kodo, Reiko Saito, Irina Chon, Takashi Kawashima, Isamu Sato, Clyde Dapat, Hironori Masaki, Takashi Odagiri
Publikováno v:
Vaccine: X, Vol 1, Iss, Pp-(2019)
Vaccine: X
Vaccine: X
Background: We estimated influenza vaccine effectiveness (VE) in 2015–2016 season against medically attended, laboratory-confirmed influenza, when quadrivalent inactivated vaccine (IIV4) was first introduced in Japan, using test-negative case-contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49045b179402d0766148886e4fd85bfa
https://doi.org/10.1016/j.jvacx.2019.100011
https://doi.org/10.1016/j.jvacx.2019.100011
Autor:
Motoi Suzuki, Koya Ariyoshi, Konosuke Morimoto, Masayuki Ishida, Akitsugu Furumoto, Yoshiko Tsuchihashi
Publikováno v:
Internal Medicine. 51(5):455-460
Objective The advantage of transbronchial biopsy (TBB) using endobronchial ultrasonography (EBUS) with a guide sheath (GS) over TBB without EBUS guidance was investigated in this study. Materials and Methods A retrospective chart review was conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeca595b311a554b2f2f0108422b997c
http://hdl.handle.net/10069/28971
http://hdl.handle.net/10069/28971
Autor:
Masayuki Hojo, Haruyuki Ishii, Yoshikazu Inoue, Ryushi Tazawa, Takahito Nei, Kazumasa Ohashi, Toshinori Takada, Masanori Yokoba, Koh Nakata, Yasunori Kasahara, Natsuki Motoi, Masahito Ebina, Chinatsu Kaneko, Shinya Urano, Yasuyuki Nasuhara, Hiroko Kanazawa, Ryosuke Eda, Jacqueline A. Kirchner, Toru Arai, Atsuyasu Sato, Etsuro Yamaguchi, Hideaki Nakayama, Yoshiko Tsuchihashi
Publikováno v:
Respiratory Medicine. 106(2):284-293
Summary Background Autoimmune pulmonary alveolar proteinosis (aPAP) is caused by granulocyte/macrophage-colony stimulating factor (GM-CSF) autoantibodies in the lung. Previously, we reported that GM-CSF inhalation therapy improved alveolar-arterial o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9999b834fffbdf3221ed375fb7460524
Autor:
Katsunori Yanagihara, Masayuki Ishida, Yoshiko Tsuchihashi, Konosuke Morimoto, Junichi Matsuda, Maiko Kojiro, Akitsugu Furumoto, Koya Ariyoshi
Publikováno v:
Kansenshogaku Zasshi. 86:778-783
A 76-year-old woman undergoing hemodialysis and having a permanent pacemaker during care elsewhere developed a shunt infection with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Vancomycin (VCM) and other antimicrobial agents were no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cc3c2dcbe26eef6dcbe6f87b835e2b5
https://doi.org/10.11150/kansenshogakuzasshi.86.778
https://doi.org/10.11150/kansenshogakuzasshi.86.778
Autor:
Masahito Ebina, Etsuro Yamaguchi, Yasunori Kasahara, Haruyuki Ishii, Ryosuke Eda, Nobuyuki Hizawa, Koichiro Tatsumi, Toru Arai, Masayuki Hojo, Junji Otsuka, Kohei Akazawa, Bruce C. Trapnell, Koh Nakata, Yoshiko Tsuchihashi, Konosuke Morimoto, Jeffrey P. Krischer, Chinatsu Kaneko, Yoshikazu Inoue, Masaki Terada, Ryushi Tazawa, Yasuyuki Nasuhara, Naohiko Tanaka, Toshihiro Nukiwa, Toshinori Takada, Masanori Yokoba, Masanori Akira
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 181:1345-1354
Rationale: Inhaled granulocyte/macrophage–colony stimulating factor (GM-CSF) is a promising therapy for pulmonary alveolar proteinosis (PAP) but has not been adequately studied. Objectives: To evaluate safety and efficacy of inhaled GM-CSF in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f269053c76477568174b27cab70a4d
https://doi.org/10.1164/rccm.200906-0978oc
https://doi.org/10.1164/rccm.200906-0978oc